Search research articles
Contact Us
Filters
Showing results (31-40 of 269) with videos related to
Page
of 27
Sort By:
Schweizerische Medizinische Wochenschrift
|
November 20, 1993
[Antiphospholipid syndrome: a new clinical entity? Part 2: pathophysiological aspects and treatment possibilities]
D A Tsakiris, P de Moerloose
Seminars in Vascular Medicine
|
June 17, 2004
Fibrin D-dimer measurement in suspected pulmonary embolism
P de Moerloose, M H Prins
Schweizerische Medizinische Wochenschrift
|
November 20, 1993
[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems]
P de Moerloose, D A Tsakiris
British Journal of Haematology
|
July 27, 2001
Congenital alpha(2)-plasmin inhibitor deficiencies: a review
R Favier, N Aoki, P de Moerloose
VASA. Zeitschrift Fur Gefasskrankheiten
|
January 1, 1996
Oral anticoagulation alone or in combination with aspirin: risks and benefits
J Hafner, P de Moerloose, H Bounameaux
Schweizerische Medizinische Wochenschrift
|
October 12, 1996
[Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism]
H Bounameaux, P de Moerloose, A Campana
Journal of Thrombosis and Haemostasis : JTH
|
July 9, 2009
Evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism
P DE Moerloose, G Reber, J Arnout
Critical Reviews in Oncology/Hematology
|
August 20, 2013
Clinical management of older persons with haemophilia
C Hermans, P de Moerloose, G Dolan
Revue Medicale Suisse
|
March 9, 2013
[Which anticoagulant agent for which patient?]
M Righini, L Mazzolai, P de Moerloose
Journal of Chromatography
|
October 26, 1988
Determination of oxybutinin chloride in pharmaceuticals by reversed-phase ion-pair liquid chromatography with two counter-ions in the eluent
J A De Schutter, P De Moerloose
Page
of 27
Search research articles
Search
Showing results (31-40 of 269) with videos related to
Sort By:
Page
of 27
Schweizerische Medizinische Wochenschrift
|
November 20, 1993
[Antiphospholipid syndrome: a new clinical entity? Part 2: pathophysiological aspects and treatment possibilities]
D A Tsakiris, P de Moerloose
Seminars in Vascular Medicine
|
June 17, 2004
Fibrin D-dimer measurement in suspected pulmonary embolism
P de Moerloose, M H Prins
Schweizerische Medizinische Wochenschrift
|
November 20, 1993
[Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems]
P de Moerloose, D A Tsakiris
British Journal of Haematology
|
July 27, 2001
Congenital alpha(2)-plasmin inhibitor deficiencies: a review
R Favier, N Aoki, P de Moerloose
VASA. Zeitschrift Fur Gefasskrankheiten
|
January 1, 1996
Oral anticoagulation alone or in combination with aspirin: risks and benefits
J Hafner, P de Moerloose, H Bounameaux
Schweizerische Medizinische Wochenschrift
|
October 12, 1996
[Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism]
H Bounameaux, P de Moerloose, A Campana
Journal of Thrombosis and Haemostasis : JTH
|
July 9, 2009
Evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism
P DE Moerloose, G Reber, J Arnout
Critical Reviews in Oncology/Hematology
|
August 20, 2013
Clinical management of older persons with haemophilia
C Hermans, P de Moerloose, G Dolan
Revue Medicale Suisse
|
March 9, 2013
[Which anticoagulant agent for which patient?]
M Righini, L Mazzolai, P de Moerloose
Journal of Chromatography
|
October 26, 1988
Determination of oxybutinin chloride in pharmaceuticals by reversed-phase ion-pair liquid chromatography with two counter-ions in the eluent
J A De Schutter, P De Moerloose
Page
of 27